Today: 21 November 2025
Subscribe
Browse Category

Investment Analysis News 31 October 2025 - 4 November 2025

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Denny’s Stock Soars on Buyout Bombshell – $620 M Deal, Q3 Misses & What’s Next

Stock Price & Recent Performance Denny’s stock was under pressure for most of 2025 before the buyout news. The share price started the year in the mid-single digits and drifted lower amid uninspiring financial results and sector-wide challenges. In fact, DENN hit a 52-week low of $2.85 earlier in the year marketbeat.com, reflecting investors’ pessimism about growth prospects. By late October, the stock was trading around the $4 mark, not far from where it stood five years ago, and well off the 52-week high of $7.73 marketbeat.com reached in late 2024. In the week heading into earnings, DENN even dipped
4 November 2025
 ·  ·  ·  · 
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir’s $500 Billion AI Surge: Record Earnings, Stock Whiplash & What’s Next for PLTR

Latest News: Record Quarter and Stock Volatility Palantir Technologies (NYSE: PLTR) just delivered a record-breaking Q3 2025, extending its meteoric run as one of this year’s hottest AI stocks. The company reported $1.18 billion in revenue (+63% YoY) and $0.21 in adjusted EPS, comfortably topping analyst forecasts of ~$1.09 B and $0.17 zerohedge.com. It was the fourth straight quarter of accelerating growth, fueled by Palantir’s push into enterprise AI. In response, management raised full-year 2025 guidance – now expecting ~$4.40 B in revenue (up from ~$4.15 B prior) and a hefty $2.15 B in adjusted operating profit zerohedge.com zerohedge.com. Despite these stellar results (which CEO
4 November 2025
 ·  ·  ·  ·  · 
Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Phio Pharmaceuticals (PHIO) Stock Skyrockets on Breakthrough Skin Cancer Trial Results – In-Depth Analysis & 2025 Outlook

Company Background and Business Model Phio Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company specializing in RNA interference (RNAi) therapies for cancer. The company was co-founded by Nobel laureate Dr. Craig Mello, a discoverer of RNAi, leveraging that legacy to develop its proprietary INTASYL™ gene-silencing technology phiopharma.com. Originally known as RXi Pharmaceuticals (founded ~2011), Phio rebranded and refocused on immuno-oncology. Its mission is to use small interfering RNA (siRNA) to “silence” genes that allow tumors to evade the immune system, thereby empowering the body’s own defenses to fight cancer ragingbull.com. Headquartered in Pennsylvania (King of Prussia) with R&D roots in Massachusetts,
3 November 2025
 ·  ·  ·  ·  · 
ON Semiconductor (ON) Stock Surges on Q3 Earnings Beat – Latest News, Financials, and Outlook

ON Semiconductor (ON) Stock Surges on Q3 Earnings Beat – Latest News, Financials, and Outlook

Recent News and Updates (Early November 2025) Earnings Release: On November 3, 2025, ON Semiconductor announced its third-quarter 2025 financial results, which were better than expected. The company reported Q3 revenue of $1.55 billion (down roughly 11% year-over-year) and a profit of $255 million timesunion.com timesunion.com. Earnings came out to $0.63 per diluted share, beating Wall Street’s consensus of $0.60. This marks a positive surprise given the headwinds the company faced earlier in the year. Management noted that the results “exceeded expectations, underscoring the strength of our strategy and the resilience of our business model,” according to CEO Hassane El-Khoury tradingview.com. He
3 November 2025
 ·  ·  ·  · 
Occidental Petroleum’s Big Deal with Berkshire & What’s Ahead: Stock Performance, News and Analysts’ View (October 2 2025)

Occidental Petroleum Primed for Action Monday: Berkshire Deal, Oil Trends & Analyst Outlook Unpacked

Latest Stock Price & Premarket Movement Friday’s close at $41.20 stockanalysis.com left Occidental near the lower end of its recent trading range (roughly $40–46 in the past month chartmill.com). In technical terms, the stock is hovering just above a chart support zone around $40.8–41.1 chartmill.com. On that basis, Monday’s premarket session showed OXY little changed, following a flat oil-futures overnight. By contrast, broad markets (Dow, S&P) were expected to open modestly higher on the heels of the Fed decision and mixed economic cues. Given OXY’s recent vol and current price, any meaningful gap either way could be triggered by oil
2 November 2025
 ·  ·  ·  ·  · 
BigBear.ai Stock’s Defense-Fueled Surge: Boom or “Mini-Palantir” Bust?

BigBear.ai Stock’s Defense-Fueled Surge: Boom or “Mini-Palantir” Bust?

Company Overview & Stock Performance Holdings is a mission-focused AI analytics provider specializing in national security and enterprise decision support. The company’s software fuses data from disparate sources and employs machine learning to aid critical operations – from military planning and intelligence analysis to supply chain optimization and airport security ir.bigbear.ai ir.bigbear.ai. Headquartered in McLean, VA, BigBear.ai went public via SPAC in late 2021 and initially struggled (its stock collapsed ~90% in 2022). However, in 2023–2025 it transformed into one of the stock market’s hottest small-cap AI plays, thanks to a confluence of defense-tech hype and headline contract wins. BigBear’s
2 November 2025
 ·  ·  ·  ·  · 
AI & Quantum Frenzy Propels IBM Stock to New Heights – Will the Rally Last?

AI & Quantum Frenzy Propels IBM Stock to New Heights – Will the Rally Last?

IBM Stock Price Rally: From Stagnation to Multi-Year Highs International Business Machines (IBM) has staged a remarkable stock comeback in 2025. After years of underperformance, “Big Blue” saw its shares roar back to life, recently trading around $307–$310 – levels not seen in decades. The stock is up roughly 30% in 2025 (through late October), dramatically outperforming the broader market (the S&P 500 is +~17% YTD). In fact, IBM even briefly hit all-time highs above $300 per share this year – a milestone that seemed far-fetched just a couple years ago. Recent trading trends underscore the bullish momentum. IBM shares
2 November 2025
 ·  ·  ·  ·  · 
BREAKING: Exxon Sues California, Citing ‘Free Speech’ in Climate Lawsuitreuters.comtimesunion.com

ExxonMobil Premarket Report (Nov 3, 2025): Q3 Beat, Analysts Bullish, But Oil Soft

In-Depth Analysis: ExxonMobil’s Q3 beat confirms its resilience. The company posted adjusted earnings of $8.1 B ($1.88/sh), topping analysts’ $1.82 estimate reuters.com. However, higher capital spending (e.g. Permian acreage buys) drove free cash flow down from last year, a point noted by TPH analyst Jeoffrey Lambujon: “higher expenditures counteracted what was otherwise positive earnings news” reuters.com. Still, the core business is firing on all cylinders – Guyana and Permian field outputs set records, and refining margins were strong enough that analysts estimate refining alone added up to $700 M of Q3 profit reuters.com. Exxon’s upstream earnings ($5.7 B in Q3) rose vs Q2,
2 November 2025
 ·  ·  ·  · 
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Soars Toward $600? AI Boom, Earnings & Analyst Targets Before Nov. 3, 2025

With its recent earnings beat and aggressive AI/cloud investments, Microsoft remains the poster child of the “AI and cloud” rally xtb.com ts2.tech. Many experts see continued momentum. Morgan Stanley notes “durable top-line demand” and flagged MSFT as a buy on any weakness investing.com investing.com. Stonehage Fleming’s Gerrit Smit observes MSFT is “becoming more of a cloud infrastructure business and a leader in enterprise AI” ts2.tech. Consensus forecasts (analyst and models) generally target $600+ by mid-2026, reflecting confidence that AI-driven growth will persist. Bottom line: Microsoft’s fundamentals remain strong (double-digit growth, huge cash flow) ts2.tech microsoft.com. Q1 results showed robust revenue
2 November 2025
 ·  ·  ·  · 
Zillow Stock Soars on Rental Boom and AI Buzz: Latest Earnings, Analyst Takes, and 2025 Outlook

Zillow Stock Soars on Rental Boom and AI Buzz: Latest Earnings, Analyst Takes, and 2025 Outlook

Stock Performance: Post-Earnings Pop but Volatile Month Zillow’s stock (ticker Z) saw a relief rally at the end of October 2025, thanks to strong earnings. Shares closed at $74.98 on Oct 31 – up +3.26 points or +4.55% for the day marketlog.com marketlog.com. This one-day spike recouped some losses from earlier in the month. However, over the five trading sessions spanning Oct 27 to Oct 31, the stock was down roughly 2%, as it began the week around the mid-$76 range and dipped before rebounding on earnings news. On a 1-month basis, Z stock is off about 2.17% marketlog.com. This
1 November 2025
 ·  ·  ·  ·  · 
Luminar (LAZR) Stock Surges on Lidar Hype – Volvo & NVIDIA Deals Ignite Investor Interest

Luminar’s LIDAR Rollercoaster: Stock Rockets on Buyout Buzz, Then Plunges Amid Cash Crunch

Stock Performance and Recent Price Action Luminar’s stock has been exceptionally volatile. On Oct. 24, 2025 the shares spiked about 31% (to ~$2.28 intraday) as the market jumped on “buyout buzz” tied to founder Austin Russell’s proposal ts2.tech ts2.tech. That move briefly pushed LAZR above its short-term resistance (~$2.10–$2.25) ts2.tech. However, within days investors were hit with negative news – missed debt payments, a halted production forecast and cash worries – causing the stock to crash. From intraday highs near $2.25 on Oct. 24, LAZR plunged to a one-year low around $1.11 by Oct. 31 ts2.tech. As of Nov. 1 the stock traded roughly
1 November 2025
 ·  ·  ·  · 
FuelCell Energy Stock Skyrockets on AI Data Center Boom – 97% Revenue Surge Ignites Green Energy Hype

FuelCell Energy Stock Surges Amid AI Data-Center Boom – But Is It Worth the Hype?

Key Facts: FCEL closed near $7.7 on Oct 30, 2025 (after a 5.5% drop on that day investing.com), down from multi-month highs above $11 mid-October. Year-to-date the stock has been volatile (β≈4.2) – up sharply on clean-energy hype and sector news, yet still below its 52-week peak (~$14) ts2.tech stockanalysis.com. Recent catalysts include big deals for industry peers (Bloom Energy’s $5B Brookfield partnership reuters.com) and bullish analyst notes on hydrogen, spurring a “rising tide” that lifted FuelCell and competitors. Wall Street remains cautiously neutral: consensus is a “Hold” rating with an average 12‑month target around $8–$9 ts2.tech marketbeat.com. FuelCell’s market
31 October 2025
 ·  ·  ·  ·  · 
1 … 14 15 16 17 18 … 31
Go toTop